Reuters logo
Spain's Grifols Q1 net profit grows 33 percent
May 6, 2014 / 6:45 AM / 3 years ago

Spain's Grifols Q1 net profit grows 33 percent

May 6 (Reuters) - Spanish pharmaceutical company Grifols , the world’s third-largest blood products maker, posted a 32.9 percent rise in first-quarter net profit on Tuesday to 121 million euros ($168 million), boosted by its acquisition of Novartis’ transfusion diagnostic business.

Barcelona-based Grifols, which generated 93 percent of sales outside Spain, said first-quarter revenue was 798 million euros, up 16.7 percent from the same period last year. ($1 = 0.7205 Euros) (Reporting By Sarah Morris; Editing by Tracy Rucinski)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below